Clinical Trials
15
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
News
Biotronik's Solia CSP S Lead Under Evaluation for Enhanced Left Bundle Branch Area Pacing
Biotronik has enrolled the first patient in the second arm of the BIO-CONDUCT study to evaluate the Solia CSP S pacing lead for left bundle branch area pacing (LBBAP).
Real-World Data Validates Long-Term Safety of BIOTRONIK's Solia S Cardiac Lead
The EP PASSION project successfully transitioned the Solia S cardiac lead post-approval study to real-world data (RWD), demonstrating the feasibility of using claims data for device surveillance.
FDA Approves Biotronik's Selectra 3D Catheter and Solia S Lead for Left Bundle Branch Area Pacing
The FDA has granted approval for Biotronik's Selectra 3D catheter, used with the Solia S lead, for left bundle branch area pacing (LBBAP).
FDA Approves Biotronik Lead and Catheter for Left Bundle Branch Area Pacing
The FDA has approved Biotronik's lead and catheter system for left bundle branch area pacing (LBBAP), offering a new option for physiological pacing.
FDA Approves Biotronik's Left Bundle Branch Area Pacing System
The FDA has granted approval for Biotronik's Selectra 3D catheter and Solia S lead system for left bundle branch area pacing (LBBAP).
Biotronik's Selectra 3D Catheter and Solia S Lead Gain FDA Approval for Left Bundle Branch Area Pacing
Biotronik received FDA approval for its Selectra 3D catheter and Solia S lead, making them the first stylet-driven system approved for Left Bundle Branch Area Pacing (LBBAP).